WITHDRAWN: Anti-cancer properties of specific Chinese herbal medicines for hepatocellular carcinoma treatment

Abstract

Aims This essay explores the anti-cancer activity of specific Chinese herbal medicines to clarify how effective Chinese herbal medicine is used for handling hepatocellular carcinoma. Methods Literature form publica domain were studied and an analysis of anti-cancer activity of specific Chinese herbal medicines is presented in this review. Results Hepatocellular carcinoma is one of the most dangerous malignant tumors in the world. The operative diagnosis of liver cancer remains a significant challenge. Although surgery tissue resection is encouraging, a high risk of recurrence and metastasis, illustrating disease-related mortality is desperately required to enhance postoperative preventive and therapeutic clinical procedures. The almost only effective clinical intervention seems to be developing advanced targeted therapies such as sorafenib for hepatocellular carcinoma patients, but there is little research in this field. Because their preventative/therapeutic properties strengthen Chinese herbal medicinal compounds, they are deemed relevant to the treatment of hepatocellular carcinoma. Conclusion: Chinese herbal medicine derivates provide multifaceted, orientated and orchestrated therapy, making it an ideal candidate for inhibiting hepatocellular tumor production and metastasis.

2α, 3α, 24‐Thrihydroxyurs‐12‐en‐24‐ursolic acid enhances the cytotoxic effect of cisplatin on oral cancer cells by down‐regulating autophagy

“…In recent years, there has been growing interest in plant‐derived functional components as potential therapeutic agents for cancer treatment and prevention. Chinese herbal medicines, particularly, have received attention due to their ability to significantly relieve cancer symptoms with fewer toxic side effects 23–26 . One such component is TEOA, a pentacyclic triterpenoid extracted from the roots of A. eriantha .…”

“…Chinese herbal medicines, particularly, have received attention due to their ability to significantly relieve cancer symptoms with fewer toxic side effects. [23][24][25][26] One such component is TEOA, a pentacyclic triterpenoid extracted from the roots of A. eriantha. Based on the available literature, TEOA has shown potential as an anticancer agent in various types of cancer cells.…”

“…Cells were seeded in 96-well plates (1 × 10 4 cells per well) and were incubated overnight to allow cell confluence. Various concentrations of TEOA (10,25,50,100,250, and 500 μM) and cisplatin (10,25,50,100,250, and 500 μM) were added into the wells, respectively. The plates were incubated at 37°C for different time points.…”

"Using Chinese Herbal Medicine to Treat Cancer Patients: A Study Incorporating Artificial Intelligence"

“…Volume 56-Issue 5 DOI: 10.26717/BJSTR.2024.56.008924 chemoprevention and therapy [94], oesophageal cancer [96], cervical cancer [97], oral cancer [98], hepatocellular carcinoma [99][100]113], lung cancer [101], prostate cancer [102], colorectal cancer [103,112], symptom management in palliative care [104], pancreatic cancer [105], cancer related fatigue [106], reactive oxygen species [107], breast cancer [108,114], and chemotherapy-induced nausea and vomiting [111], to name a few.…”

Biodegradable Manganese-Containing Mesoporous Silica Nanoparticles for Precisely Controlled Quercetin Delivery

“…With the deep research of Chinese herbal medicines, the critical role of Chinese herbal medicines in chemotherapy of tumor is confirmed. − Quercetin (Que) as an flavonol compound with unique bioactivity exhibits a variety of biological activities, including antibacterial, antiviral, antioxidant, cardiovascular protection, and blood pressure lowering . Recently, the antitumor effects and immunomodulatory effects for lung cancer have been proved, which attract researchers’ great attention . However, the disadvantages of quercetin, such as low solubility, poor stability, and low bioavailability, restricted its clinical application …”